Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001636178-26-000008

CFO AND TREASURER sold 10,000 shares at an average $577.89 ($5,778,922)

  • CFO AND TREASURER acquired 10,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

EDGEMOND JAMES · CFO AND TREASURER

Table I: Non-derivative

9 lines
Date Transaction Shares Price Value Owned after D/I
2026-04-09 Exercise or conversion : show line 1 in the form 10b5-1 +10,000 $135.42 $1,354,200 28,876 D
2026-04-09 Sale : show line 2 in the form 10b5-1 −560 $574.87 $321,926 28,316 D
2026-04-09 Sale : show line 3 in the form 10b5-1 −1,956 $575.53 $1,125,731 26,360 D
2026-04-09 Sale : show line 4 in the form 10b5-1 −1,586 $576.63 $914,530 24,774 D
2026-04-09 Sale : show line 5 in the form 10b5-1 −1,617 $577.77 $934,247 23,157 D
2026-04-09 Sale : show line 6 in the form 10b5-1 −1,139 $578.52 $658,939 22,018 D
2026-04-09 Sale : show line 7 in the form 10b5-1 −1,224 $579.75 $709,613 20,794 D
2026-04-09 Sale : show line 8 in the form 10b5-1 −1,756 $580.64 $1,019,602 19,038 D
2026-04-09 Sale : show line 9 in the form 10b5-1 −162 $582.30 $94,333 18,876 D
Open-market sales · 10,000 sh · avg $577.89 · $5,778,922

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-04-09 Exercise or conversion : show line 10 in the form 10b5-1 Stock Option −10,000 102,500 D
Loading xslF345X06/primarydocument.xml…